Literature DB >> 15488797

Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery.

Keita Yamakiri1, Eisuke Uchino, Katsuaki Kimura, Taiji Sakamoto.   

Abstract

AIM: To study the effects of intracameral injection of triamcinolone acetonide on visualizing and removing the vitreous body from the anterior chamber in cataract surgery.
DESIGN: Observational case series.
METHODS: Six eyes of six patients had the posterior capsule ruptured and the vitreous body prolapsed or incarcerated into the anterior chamber during cataract surgery. To visualize vitreous body, triamcinolone acetonide solution was injected into the anterior chamber and the vitreous body was resected. The intraoperative findings, results, and complications were evaluated.
RESULTS: Vitreous body was well observed under surgical microscopy and was resected safely and completely. Minimum inflammation was observed postoperatively, and the patients obtained good visual acuity. No serious complications were found. One eye showed increased intraocular pressure (40 mm Hg), which was normalized by additional washing of the anterior chamber.
CONCLUSIONS: Appropriate use of intracameral triamcinolone acetonide is beneficial to visualize and remove the vitreous body from the anterior chamber during cataract surgery, and sufficient washing of the anterior chamber is necessary to avoid complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15488797     DOI: 10.1016/j.ajo.2004.05.033

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Glaucoma and retained-triamcinolone in pediatric cataract surgery.

Authors:  M E Wilson; R H Trivedi; D Tadros
Journal:  Eye (Lond)       Date:  2016-06-10       Impact factor: 3.775

2.  Use of triamcinolone during vitrectomy surgery to visualize membranes and vitreous.

Authors:  Steven M Couch; Sophie J Bakri
Journal:  Clin Ophthalmol       Date:  2008-12

3.  The visualisation of vitreous using surface modified poly(lactic-co-glycolic acid) microparticles.

Authors:  David Y S Chau; Naing L Tint; Russell J Collighan; Martin Griffin; Harminder S Dua; Kevin M Shakesheff; Felicity R A J Rose
Journal:  Br J Ophthalmol       Date:  2010-05       Impact factor: 4.638

Review 4.  Visualizing vitreous in vitrectomy by triamcinolone.

Authors:  Taiji Sakamoto; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-06-20       Impact factor: 3.117

5.  Comparison of intracameral dexamethasone and intracameral triamcinolone acetonide injection at the end of phacoemulsification surgery.

Authors:  Gokhan Ozge; Onder Ayyildiz; Murat Kucukevcilioglu; Tarkan Mumcuoglu
Journal:  Indian J Ophthalmol       Date:  2015-03       Impact factor: 1.848

6.  Comparison of intracameral dexamethasone and intracameral triamcinolone acetonide injection at the end of phacoemulsification surgery.

Authors:  Sirel Gur Gungor; Begum Bulam; Ahmet Akman; Meric Colak
Journal:  Indian J Ophthalmol       Date:  2014-08       Impact factor: 1.848

Review 7.  Posterior capsular rent: Prevention and management.

Authors:  Arup Chakrabarti; Nazneen Nazm
Journal:  Indian J Ophthalmol       Date:  2017-12       Impact factor: 1.848

8.  Impact of fluidic parameters during phacoemulsification on the anterior vitreous face behavior: Experimental study.

Authors:  Vaishali Vasavada; Samaresh Srivastava; Viraj Vasavada; Shail Vasavada; Abhay R Vasavada; Aditya Sudhalkar; Alper Bilgic
Journal:  Indian J Ophthalmol       Date:  2019-10       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.